Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey

被引:81
作者
Cirillo, DJ [1 ]
Agrawal, Y [1 ]
Cassano, PA [1 ]
机构
[1] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA
关键词
antioxidants; apoproteins; cholesterol; forced expiratory volume; lipoproteins; HDL; LDL;
D O I
10.1093/aje/155.9.842
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Studies considering the association between total cholesterol and noncardiovascular mortality, particularly from respiratory disease, yield inconclusive findings. To explore this question, the relation of lipids to pulmonary function, specifically forced expiratory volume in 1 second (FEV1), was investigated in the Third National Health and Nutrition Examination Survey. Conducted in the United States in 1988-1994 among adults aged greater than or equal to17 years, this survey measured serum lipids, FEV1, and confounding factors including smoking and antioxidants. Multiple linear regression analysis explored the relation of FEV1/height(2) to low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, and their respective apolipoproteins (apo) B and A-I. A standard deviation increase in HDL cholesterol or apo A-I was associated with an FEV1 increase of 43 ml (95% confidence interval (CI): 30, 56) or 29 ml (95% CI: 11, 47), respectively, for an average-height adult. A standard deviation increase in LDL cholesterol or apo B was associated with an FEV1 decrease of -24 ml (95% CI: -43, -5) or -53 ml (95% CI: -74, -32), respectively, adjusted for serum antioxidant status. The lipid subfractions were differentially associated with FEV1 consistent with the possibility that LDL cholesterol contributes to endogenous oxidative burden while HDL cholesterol attenuates inflammatory tissue damage. Whether these associations are causal remains to be determined.
引用
收藏
页码:842 / 848
页数:7
相关论文
共 27 条
[11]  
Hu GZ, 2000, AM J EPIDEMIOL, V151, P975, DOI 10.1093/oxfordjournals.aje.a010141
[12]   LOW SERUM-CHOLESTEROL AND MORTALITY - WHICH IS THE CAUSE AND WHICH IS THE EFFECT [J].
IRIBARREN, C ;
REED, DM ;
CHEN, R ;
YANO, K ;
DWYER, JH .
CIRCULATION, 1995, 92 (09) :2396-2403
[13]   Serum total cholesterol and risk of hospitalization, and death from respiratory disease [J].
Iribarren, C ;
Jacobs, DR ;
Sidney, S ;
Claxton, AJ ;
Gross, MD ;
Sadler, M ;
Blackburn, H .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (06) :1191-1202
[14]   REPORT OF THE CONFERENCE ON LOW BLOOD CHOLESTEROL - MORTALITY ASSOCIATIONS [J].
JACOBS, D ;
BLACKBURN, H ;
HIGGINS, M ;
REED, D ;
ISO, H ;
MCMILLAN, G ;
NEATON, J ;
NELSON, J ;
POTTER, J ;
RIFKIND, B ;
ROSSOUW, J ;
SHEKELLE, R ;
YUSUF, S .
CIRCULATION, 1992, 86 (03) :1046-1060
[15]  
Jacobs DR, 2000, AM J EPIDEMIOL, V151, P748
[16]  
JACOBS DR, 1993, ANNU REV PUBL HEALTH, V14, P95
[17]   Obstructive lung disease and low lung function in adults in the United States -: Data from the National Health and Nutrition Examination Survey, 1988-1994 [J].
Mannino, DM ;
Gagnon, RC ;
Petty, TL ;
Lydick, E .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (11) :1683-1689
[18]   Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials [J].
Muldoon, MF ;
Manuck, SB ;
Mendelsohn, AB ;
Kaplan, JR ;
Belle, SH .
BRITISH MEDICAL JOURNAL, 2001, 322 (7277) :11-15
[19]   The Yin and Yang of oxidation in the development of the fatty streak - A review based on the 1994 George Lyman Duff Memorial Lecture [J].
Navab, M ;
Berliner, JA ;
Watson, AD ;
Hama, SY ;
Territo, MC ;
Lusis, AJ ;
Shih, DM ;
VanLenten, BJ ;
Frank, JS ;
Demer, LL ;
Edwards, PA ;
Fogelman, AM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (07) :831-842
[20]   SERUM-CHOLESTEROL LEVEL AND MORTALITY FINDINGS FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
NEATON, JD ;
BLACKBURN, H ;
JACOBS, D ;
KULLER, L ;
LEE, DJ ;
SHERWIN, R ;
SHIH, J ;
STAMLER, J ;
WENTWORTH, D .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (07) :1490-1500